RAD51C Antikörper

Han, Ruan, Huen, Wang, Xie, Fu, Liu, Huang: "BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability." in: Nature communications, Vol. 8, Issue 1, pp. 1470, (2017) (PubMed).

Wu, Huang, Jiao, Ding, Zhang, Chen, Wang, Li, Huo: "Olaquindox disrupts tight junction integrity and cytoskeleton architecture in mouse Sertoli cells." in: Oncotarget, Vol. 8, Issue 51, pp. 88630-88644, (2017) (PubMed).

Gayarre, Martín-Gimeno, Osorio, Paumard, Barroso, Fernández, de la Hoya, Rojo, Caldés, Palacios, Urioste, Benítez, García: "Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes." in: British journal of cancer, Vol. 117, Issue 7, pp. 1048-1062, (2017) (PubMed).

Park, Singh, Nassar, Zhang, Freund, Hanenberg, Meetei, Andreassen: "Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair." in: Oncogene, Vol. 33, Issue 40, pp. 4803-12, (2014) (PubMed).

Min, Im, Yoon, Song, Nam, Hur, Kim, Lee, Han, Oh, Kim, OConnor, Kim, Bang: "RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib." in: Molecular cancer therapeutics, Vol. 12, Issue 6, pp. 865-77, (2013) (PubMed).

Jensen, Ozes, Kim, Estep, Kowalczykowski: "BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage." in: DNA repair, Vol. 12, Issue 4, pp. 306-11, (2013) (PubMed).

Huang, Wang, Dhillon, Calses, Villegas, Mitchell, Tewari, Kemp, Taniguchi: "Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity." in: Molecular cancer research : MCR, Vol. 11, Issue 12, pp. 1564-73, (2013) (PubMed).

Mao, Tian, Van Meter, Ke, Gorbunova, Seluanov: "Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Issue 29, pp. 11800-5, (2012) (PubMed).

Wang, Huang, Calses, Kemp, Taniguchi: "MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition." in: Cancer research, Vol. 72, Issue 16, pp. 4037-46, (2012) (PubMed).

Chun, Buechelmaier, Powell: "Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway." in: Molecular and cellular biology, Vol. 33, Issue 2, pp. 387-95, (2012) (PubMed).